Pinnacle Wealth Planning Services’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23.5K Buy
1,165
+882
+312% +$17.8K ﹤0.01% 1706
2026
Q1
$5.54K Sell
283
-1,332
-82% -$32.6K ﹤0.01% 2232
2025
Q4
$43.3K Buy
+1,615
New +$41.6K ﹤0.01% 1299
2021
Q1
Sell
-230
Closed -$5K 419
2020
Q4
$5K Buy
+230
New +$4.48K ﹤0.01% 1634

Other funds holding AMPH

Pinnacle Wealth Planning Services's AMPH Position: Q2 2026 in Review

Pinnacle Wealth Planning Services increased its Amphastar Pharmaceuticals (AMPH) stake by 312% in Q2 2026, buying an estimated $17.8K and bringing the position to 1,165 shares worth $23.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1706.

Pinnacle Wealth Planning Services first reported a position in AMPH in Q4 2020 and has held it in 4 quarters since. The position peaked at $43.3K in Q4 2025. 212 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.

  • Pinnacle Wealth Planning Services held 1,165 shares of Amphastar Pharmaceuticals worth $23.5K as of Q2 2026.
  • Pinnacle Wealth Planning Services bought 882 Amphastar Pharmaceuticals shares in Q2 2026, an estimated $17.8K.
  • Amphastar Pharmaceuticals made up ﹤0.01% of Pinnacle Wealth Planning Services's portfolio in Q2 2026, its #1706 holding.
  • Pinnacle Wealth Planning Services first reported a position in Amphastar Pharmaceuticals in Q4 2020 and has held it in 4 quarters since.
  • Pinnacle Wealth Planning Services's Amphastar Pharmaceuticals position peaked at $43.3K in Q4 2025.
  • 212 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.

Based on Pinnacle Wealth Planning Services's 13F filing for Q2 2026, filed 7 Aug 2026.